Skip to main content
. 2017 Sep 7;2(1):e000061. doi: 10.1136/bmjophth-2016-000061

Figure 3.

Figure 3

Case 3 could be stopped using 2% topical ganciclovir at 3rd month without any recurrent symptoms. IOP, intraocular pressure; VA, visual acuity.